ISD Immunotech (private company)
See something wrong or missing? Let us know
Offices:Aarhus
Industry:BiotechHealth services
Business model:B2B
ISD Immunotech is developing a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to ISD Immunotech
Name | Criteria | |
---|---|---|
![]() |
Draupnir Bio
43%
|
|
![]() |
Leyden Labs
43%
|
|
![]() |
Synendos Therapeutics
43%
|
|
![]() |
ReViral
43%
|
|
![]() |
Ori Biotech
43%
|
|
![]() |
Turbine
43%
|
|
![]() |
Aprea Therapeutics
43%
|
|
![]() |
Zelluna Immunotherapy As
43%
|
|
![]() |
Achilles Therapeutics
43%
|
|
![]() |
Entia
43%
|
|